Clinical Trial

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The aim of this study is to determine whether 9-cis-beta Caroten rich D. Brdawiil extract is effective in the treatment of retinitis pigmentosa in adolescent patients.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2013-12-20; most recent amendment 2025-09-30.
Trial Details
NCT Number NCT02018692
Lead Sponsor Sheba Medical Center
Conditions Retinitis Pigmentosa
Enrollment 30 participants
Start Date 2026-03-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-06